missing translation for 'onlineSavingsMsg'
Learn More

enQuireBio™ Recombinant HIV-1 gag p17-p24 Protein

A cDNA sequence encoding the HIV-1 gag p17-p24 was constructed and used to recombinantly synthesize the protein.

248.00 EUR - 1810.00 EUR

Specifications

Name HIV-1 gag p17-p24 Protein
Regulatory Status Research Use Only
Endotoxin Concentration Not Determined. Testing recommended prior to use in cell culture and can be performed upon request.
Product Type Recombinant Protein
Cross Reactivity HIV
View More Specs

Products 3
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
15949808
View Documents
enQuireBio™
QP12243-100ug
100 μg
248.00 EUR
100µg
Please to purchase this item. Need a web account? Register with us today!
15969808
View Documents
enQuireBio™
QP12243-500ug
500 μg
943.00 EUR
500µg
Please to purchase this item. Need a web account? Register with us today!
15959808
View Documents
enQuireBio™
QP12243-1mg
1 mg
1810.00 EUR
1mg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Specifications

Specifications

HIV-1 gag p17-p24 Protein
Not Determined. Testing recommended prior to use in cell culture and can be performed upon request.
HIV
Untagged
Greater than 95.0% as determined by HPLC analysis and SDS-PAGE.
Research Use Only
Recombinant Protein
E. coli
20mM PBS pH 7.8, 20mM NaCl 0.5M, 1mM DTT and 8M urea.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.